Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (OTCPK:NVIVQ)

InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study

Business Wire December 20, 2016

InVivo Therapeutics to Present at 2016 Tissue Engineering & Regenerative Medicine International Society Americas Conference

Business Wire December 12, 2016

InVivo Therapeutics Appoints Melanie Morel-Ferris, C.P.A. as Interim CFO, Replacing Steven McAllister in Role

Business Wire December 8, 2016

InVivo Therapeutics Announces New Patient Enrollment into The INSPIRE Study

Business Wire November 17, 2016

InVivo Therapeutics to Present at Neuroscience 2016

Business Wire November 10, 2016

InVivo Therapeutics Announces University of Iowa Hospitals and Clinics as New Site for INSPIRE Study

Business Wire November 9, 2016

InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update

Business Wire November 4, 2016

InVivo Therapeutics Announces Allegheny General Hospital as New Site for INSPIRE Study

Business Wire November 3, 2016

InVivo Therapeutics Announces Appointment of Jeffrey Hatfield to Board of Directors

Business Wire November 2, 2016

InVivo Therapeutics to Present at Upcoming Science and Advocacy Meetings

Business Wire October 24, 2016

InVivo Therapeutics Announces Beth Israel Deaconess Medical Center as New Site for INSPIRE Study

Business Wire October 20, 2016

InVivo Therapeutics Announces Foothills Medical Centre in Calgary, Alberta as New Canadian Site for INSPIRE Study

Business Wire October 19, 2016

InVivo Therapeutics to Present at Cell & Gene Meeting on the Mesa

Business Wire September 26, 2016

InVivo Therapeutics Announces Late-Breaking Oral Presentation at the 2016 Congress of Neurological Surgeons Annual Meeting

Business Wire September 20, 2016

InVivo Therapeutics Announces Oral Platform Presentation at 2016 Congress of Neurological Surgeons Annual Meeting

Business Wire September 14, 2016

InVivo Therapeutics to Present at 55th International Spinal Cord Society Annual Scientific Meeting

Business Wire September 7, 2016

InVivo Therapeutics to Participate in Upcoming Investor Conferences

Business Wire September 6, 2016

InVivo Therapeutics Announces Northwestern Medicine as New Site for INSPIRE Study

Business Wire August 18, 2016

InVivo Therapeutics Announces Fifth Patient Conversion in INSPIRE Study of the Neuro-Spinal Scaffold™

Business Wire August 17, 2016

InVivo Therapeutics Appoints Pamela Stahl as Chief Commercial Officer

Business Wire August 11, 2016